-
Signature
-
/s/ James Basta, attorney-in-fact
-
Stock symbol
-
NTLA
-
Transactions as of
-
Jun 30, 2025
-
Transactions value $
-
-$29,068
-
Form type
-
4
-
Date filed
-
7/2/2025, 05:50 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| GOODMAN JESSE |
Director |
C/O INTELLIA THERAPEUTICS, INC., 40 ERIE STREET; SUITE 130, CAMBRIDGE |
/s/ James Basta, attorney-in-fact |
2025-07-02 |
0001756929 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
NTLA |
Common Stock |
Sale |
-$14.8K |
-1.55K |
-5.64% |
$9.56 |
25.9K |
Jun 30, 2025 |
Direct |
F1 |
| transaction |
NTLA |
Common Stock |
Sale |
-$14.3K |
-1.55K |
-5.97% |
$9.23 |
24.4K |
Jul 1, 2025 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: